Defining the genomic architecture of Age-related Macular Degeneration (AMD) to improve diagnosis, treatment, and prevention.

AMD is the most common cause of severe vision loss

among the elderly. 

The condition is strongly influenced by genomic variation. 

For more than 20 years, the IAMDGC and its individual members have advanced understanding of the genomics of AMD.  Learn more about our resources and datasets here

Our research has informed genetic testing capabilities

that are useful in diagnosis and treatment. 

Contact us:

Susan Halloran Blanton, PhD

Project Manager, IAMDGC